Archives

by in
Entry Author Date Location
Boston Tech Roundup: Attune, Cognex, GreenBytes, LevelUp, & More 04/04/13 Boston
Enzon, under Pressure from Carl Icahn, Seeks Buyer 12/17/12 New York
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More 04/27/12 San Diego
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas 04/01/11 Seattle
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
Motricity’s Ryan Wuerch on the Post-IPO Game Plan, International Expansion, and the New Wave of Mobile 10/08/10 Seattle
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say 09/22/10 Boston
Genzyme Agrees to Sell Genetics Unit to LabCorp for $925M 09/13/10 Boston
Susan Windham-Bannister on the State of the State’s $1B Life Sciences Initiative, Part II 08/18/10 Boston
Susan Windham-Bannister on the State of the State’s $1B Life Sciences Initiative, Part I 08/17/10 Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis? 07/29/10 Boston
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation 07/23/10 Boston
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve 07/01/10 Boston
Reports: Biogen Picks Exelixis Chief George Scangos as New CEO 06/30/10 Boston
Motricity Completes IPO, Settles For $50M 06/18/10 Seattle
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News 06/18/10 Boston
Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year 06/16/10 Boston
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
Genzyme Borrows $1B for Stock Buyback 06/15/10 Boston
Modumetal Closes Series B, TerraPower Pulls In $35M, Vertafore Bought for $1.4B, & More Seattle-Area Deals News 06/15/10 Seattle
Motricity, Riding the Mobile Software Wave, Primed for $85M IPO This Week 06/14/10 Seattle
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote 06/09/10 Boston
Biogen’s CEO Retires Tomorrow, COO to Follow 06/07/10 Boston
Genzyme Taps Amgen Vet for Board 06/07/10 Boston
Page 1 of 6 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.